Genomic Assays in Early Breast Cancer

Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEarlyBCGenomicAssays21).

2356 232

Suggested Podcasts

Environmental Law Institute

Mark P. McDonough

Heritage Radio Network

Ev'Yan Whitney, Sexuality Doula®

Podcast Network Asia